Strategies for chemokine antagonists as therapeutics

Author： Proudfoot A.E.I. Power C.A. Rommel C. Wells T.N.C.

ISSN： 1044-5323

Source： Seminars in Immunology, Vol.15, Iss.1, 2003-02, pp. : 57-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA Therapeutics: The Emerging Anticancer Strategies

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 3, 2014-09 ,pp. : 286-296

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Emerging Concepts and Therapeutics Strategies for the Treatment of Brain Tumors)

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 8, 2014-10 ,pp. : 1063-1064

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?

By Bourgier Céline

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 699-712

Springer Publishing Company

Access to resources Recommend Favorite

Nanoparticle strategies for cancer therapeutics: Nucleic acids, polyamines, bovine serum amine oxidase and iron oxide nanoparticles (Review)

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 5-16

Spandidos Publications

Access to resources Recommend Favorite

Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 54-72

Bentham Science Publishers

Access to resources Recommend Favorite